1. Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions.
- Author
-
Włodarczak, Adrian, Rola, Piotr, Włodarczak, Szymon, Szudrowicz, Marek, Giniewicz, Katarzyna, Łanocha, Magdalena, Jaroszewska-Pozorska, Joanna, Barycki, Mateusz, Furtan, Łukasz, Kędzierska, Michalina, Włodarczak, Piotr, Doroszko, Adrian, and Lesiak, Maciej
- Subjects
- *
ACUTE coronary syndrome , *MYOCARDIAL infarction , *PERCUTANEOUS coronary intervention , *TREATMENT effectiveness , *DRUG-eluting stents , *THROMBOSIS - Abstract
Background: The acute coronary syndrome (ACS) continues to be a fundamental indication for revascularization by percutaneous coronary intervention (PCI). Drug-eluting stent (DES) implantation remains a part of contemporary practice but permanent caging of the vascular structure with the metallic stent structure may increase the rate of device-related adverse clinical events. As an alternative to classic metallic DESs, the bioresorbable scaffolds (BRSs) have emerged as a temporary vascular support technology. We evaluated the mid-term outcomes of two generations of bioresorbable scaffolds—Absorb (Abbott-Vascular, Chicago, IL, USA) and Magmaris (Biotronik, Germany)—in patients with non-ST-elevation ACS. Methods: The study cohort consisted of 193 subjects after Magmaris implantation and 160 patients following Absorb implantation in large-vessel lesions. Results: At 2 years, a significantly lower rate of a primary outcome (cardiac death, myocardial infarction, stent thrombosis) was observed with Magmaris (5.2% vs. 15%; p = 0.002). In addition, we observed a significantly lower rate of MI in the target vessel (2.6% vs. 9.4%; p = 0.009) and a lower rate of scaffold thrombosis (0% vs. 3.7%; p = 0.008). The TLF rate between the two groups was not significantly different. Conclusion: Magmaris demonstrated a good safety profile and more favorable clinical outcomes when compared to Absorb in patients with non-ST-elevation ACS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF